|
CH 251, Respiratory Drugs, Skeletal Muscle Relaxants,
Antihypertensive Drugs, Angina Pectoris,
Cardiac Arrhythmias,
Congestive Heart Failure,
Coagulation
Disorders and Hyperlipidia, Endocrine Pharmacology,
Male and Female Hormones,
Thyroid and Parathyroid,
Diabetes
Final Exam Objectives
RESPIRATORY
DRUGS
Respiratory system mediates gas exchange between external
environment and blood.
| Respiratory drugs |
| Acute and minor problems |
chronic and serious problems |
| Eg. Nasal congestion, coughing, Allergies |
eg. Bronchial asthma, chronic bronchitis,
emphysema |
RESPIRATORY TRACK IRRITATION AND CONTROL
RESPIRATORY SECRETIONS
(coughing, irritation from cold,
allergies etc)
|
Drug
Class
|
Mechanism
|
Examples
|
Side
effects
|
|
Antitussive: for cough with cold or minor irritation.
|
Usually combined with aspirin or acetaminophen.
Opiate drugs suppress cough reflex by central inhibitory effect.
Non-opioid work by inhibiting irritant effects of histamine or by
local anesthetic action on the respiratory epithelium.
|
Codeine, hydrocodone
|
Sedation, dizziness, GI upset.
|
|
Decongestants:
Mucosal discharge, allergies
|
Alpha-1 agonists: bind ot receptors located on blood
vessels and stimulate casoconstriction hence drying up mucosal vasculature.
|
Ephedrine, epinephrine
|
Headache, dizziness, nervousness, nausea.
Prolonged use causes more adverse effects.
|
|
Antihistamines: for sedation and treatment of
allergies
|
Histamine is endogenous chemical involved in normal
regulation of physiological functions eg gastric secretions and
hypersensitivity reactions. It works by exerting effect on two receptors
H1 (found in vascular, GI track and respiratory tissue) and H2
(responsible for gastric secretions, can cause peptic ulcers).
Antihistamines block the receptors.
|
Azatadine, clemastine (Tavist), tefenadine (Seldane)
|
Sedation, fatigue, dizziness, GI stress etc.
|
|
Mucolytics and expectorants: used in colds and pneumonia or chronic bronchitis.
|
Mucolytics attempt to decrease viscosity of
respiratory secretions.
Expectorants facilitate production and ejection of
mucus.
|
Acetylcysteine (Mucosil)- inhalation drug.
|
GI irritation
|
DRUGS USED TO MAINTAIN
AIRWAY PATENCY IN OBSTRUCTIVE PULMONARY
DISEASE
|
Drug
Class
|
Mechanism
|
Examples
|
Side
effects
|
|
Beta-adrenergic Agonists
|
Relax the bronchiole smooth muscle hence prevent
obstruction. Usually delivered by inhalation
|
Albuterol, epinephrine, ephedrine
|
Bronchial irritation.
Other effects depend on route of administration.
|
|
Xanthine derivatives
|
Work by causing bronchodilation by inhibition of Ca
ion release or prostaglandin inhibition.
It may also increases respiratory muscle strength, accelerates
mucociliary transport, decreases pulmonary artery pressure etc.
|
Theophylline, dyphylline
|
Toxicity, early signs are nausea, confusion,
irritability etc. Serious side effects may be cardiac arrhythmias or
seizures.
|
|
Anticholinergic drugs
|
Block the muscarinic receptors to cause
bronchoconstriction (not the first choice of drugs)
|
Atropine
|
Dry mouth, constipation, urinary retention, confusion
etc.
|
|
Coricosteroids: most effective for asthma.
|
Control the inflammation mediated bronchospasm by
inhibiting the the production of prostaglandins and leukitrienes.
|
Flunisolide
|
Osteoporosis, skin breakdown, muscle wasting,
aggravationof diabetes and hypertionsion.
|
|
Cromolyn Sodium: prevent bronchospasm with asthma
|
Prevents bronchoconsitriction by inhibiting release
of inflammatory mediators like histamine and leukotrienes.
|
Carmolyn sodium
|
Irritation of upper respiratory passages.
|
TREATMENT
OF BRONCHIAL ASTHMA
Asthma is characterized by bronchial
smooth muscle spasm, airway inflammation and mucous plugging of the airways.
In some cases triggers for asthma attack are well defined eg pollen, dust,
chemicals etc. Other factors may
include exercise, cold, stress etc.
Cause: airway inflammation seems to be the
initiating factor. Cells like the macrophages, neutrophils etc cause release of
inflammatory chemicals like the prostaglandins, leukotrienes, histamine etc.
Treatment and Management: has been
bronchodilators (eg beta agonists) and coriticosteroids. Patients should try and
recognize the triggers for their asthma and consequently avoid them.
RESPIRATORY PROBLEMS IN
CYSTIC FIBROSIS
Hereditory disease affecting all major exocrine glands
resulting in thick viscous secretions. These secretions cause obstruction in
major ducts of glands and organs. Respiratory problems like pneumonia,
bronchiectasis, pulmonary fibrosis and pulmonary infections are very common.
Treatment: bronchodilators and mucolytic/expectorant
drugs help unplug the mucous. Infections
can be treated by antibiotics. Breathing
exercises etc also help.
Concerns in Rehabilitation:
-
proper respiratory hygiene
-
therapists can facilitate the pharmacotherapeutic effect of drugs by
performing postural drainage and breathing exercises
-
coordinate treatment with therapy
-
be aware of patients with bronchospastic attacks and keep dilators handy
-
be aware of side effects of dilators eg cardiac arrhythmias and toxicity.
|